Insider · CIK 0001916310

Oosthuizen Johannes Jacobus

Reports to the SEC for 2 companies · RAHWAY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001916310

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-22	VYLRVylor Inc.A Award	Director	AAward	+2,610 sh	—	—	2,610
2026-05-05	MRKMerck & Co., Inc. · Restricted Stock UnitA Award	EVP, Oncology & Int?l	AAward	+10.6K sh	—	—	10,605
2026-05-05	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	EVP, Oncology & Int?l	AAward	+31K sh	—	—	31,044
2026-04-29	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+1,377 sh	$110.03	+$152K	22,574.389
2026-04-29	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−679 sh	$110.03	−$74.7K	21,895.389
2026-04-29	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−1,377 sh	—	—	2,755
2026-02-06	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−15K sh	$121.87	−$1.83M	21,197.389
2026-01-26	MRKMerck & Co., Inc.A Award	EVP, Oncology & Int?l	AAward	+5,026 sh	$107.40	+$540K	36,197.389
2025-04-29	MRKMerck & Co., Inc. · Restricted Stock UnitA Award	EVP, Oncology & Int?l	AAward	+4,132 sh	—	—	4,132
2025-04-29	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	EVP, Oncology & Int?l	AAward	+18.8K sh	—	—	18,807
2025-02-19	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−8,500 sh	$84.09	−$715K	30,705.474
2025-02-08	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+13K sh	$87.28	+$1.13M	45,609.474
2025-02-08	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−6,404 sh	$87.28	−$559K	39,205.474
2025-02-08	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−13K sh	—	—	0
2025-01-27	MRKMerck & Co., Inc.A Award	EVP, Oncology & Int?l	AAward	+8,664 sh	$97.94	+$849K	32,607.474
2024-05-04	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+912 sh	$127.51	+$116K	24,270.949
2024-05-04	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−450 sh	$127.51	−$57.4K	23,820.949
2024-05-04	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−912 sh	—	—	0
2024-04-30	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	EVP, Oncology & Int?l	AAward	+20.5K sh	—	—	20,508
2024-02-02	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+6,773 sh	$75.36	+$510K	28,122.345
2024-02-02	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+7,045 sh	$73.73	+$519K	35,167.345
2024-02-02	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+7,119 sh	$87.10	+$620K	42,286.345
2024-02-02	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−19K sh	$127.17	−$2.41M	23,327.345
2024-02-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−6,773 sh	—	—	0
2024-02-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−7,045 sh	—	—	7,049
2024-02-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−7,119 sh	—	—	14,240
2024-01-22	MRKMerck & Co., Inc.A Award	EVP, Oncology & Int?l	AAward	+3,133 sh	$119.43	+$374K	21,349.345
2023-11-09	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−2,081 sh	$102.38	−$213K	18,190.657
2023-10-30	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+915 sh	$102.82	+$94.1K	20,722.657
2023-10-30	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−451 sh	$102.82	−$46.4K	20,271.657
2023-10-30	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−915 sh	—	—	0
2023-05-04	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+907 sh	$118.22	+$107K	20,206.748
2023-05-04	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−447 sh	$118.22	−$52.8K	19,759.748
2023-05-04	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−907 sh	—	—	912
2023-05-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	EVP, Oncology & Int?l	AAward	+20.7K sh	—	—	20,747
2023-05-01	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+866 sh	$115.47	+$100K	19,726.748
2023-05-01	MRKMerck & Co., Inc.F Tax Payment	EVP, Oncology & Int?l	FTax Payment	−427 sh	$115.47	−$49.3K	19,299.748
2023-05-01	MRKMerck & Co., Inc. · Restricted Stock UnitM Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−866 sh	—	—	0
2023-01-23	MRKMerck & Co., Inc.A Award	EVP, Oncology & Int?l	AAward	+2,091 sh	$109.88	+$230K	18,821.881
2022-11-09	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−1,795 sh	$103.21	−$185K	16,730.881
2022-11-07	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+14.7K sh	—	—	26,046.881
2022-11-07	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+17.5K sh	—	—	43,501.881
2022-11-07	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+13.5K sh	—	—	57,041.881
2022-11-07	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+7,045 sh	—	—	64,086.881
2022-11-07	MRKMerck & Co., Inc.S Sale	EVP, Oncology & Int?l	SSale	−45.6K sh	$99.47	−$4.53M	18,525.881
2022-11-07	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−14.7K sh	—	—	0
2022-11-07	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−17.5K sh	—	—	0
2022-11-07	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−13.5K sh	—	—	6,773
2022-11-07	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	−7,045 sh	—	—	14,094
2022-10-30	MRKMerck & Co., Inc.M Exercise/Conversion	EVP, Oncology & Int?l	MExercise/Conversion	+913 sh	$100.77	+$92K	11,793.881

Recent filings

Accepted (ET)
Oct 264
Oosthuizen Johannes Jacobus0001225208-26-008498
SEC(opens sec.gov)
May 74
Oosthuizen Johannes Jacobus0000310158-26-000121
SEC(opens sec.gov)
May 14
Oosthuizen Johannes Jacobus0000310158-26-000078
SEC(opens sec.gov)
Feb 64
Oosthuizen Johannes Jacobus0000310158-26-000040
SEC(opens sec.gov)
Jan 284
Oosthuizen Johannes Jacobus0000310158-26-000020
SEC(opens sec.gov)
May 14
Oosthuizen Johannes Jacobus0001127602-25-013043
SEC(opens sec.gov)
Feb 204
Oosthuizen Johannes Jacobus0001127602-25-005928
SEC(opens sec.gov)
Feb 114
Oosthuizen Johannes Jacobus0001127602-25-004103
SEC(opens sec.gov)
Jan 294
Oosthuizen Johannes Jacobus0001127602-25-002351
SEC(opens sec.gov)
May 64
Oosthuizen Johannes Jacobus0001127602-24-014263
SEC(opens sec.gov)
May 24
Oosthuizen Johannes Jacobus0001127602-24-013953
SEC(opens sec.gov)
Feb 54
Oosthuizen Johannes Jacobus0001127602-24-003352
SEC(opens sec.gov)

Companies

Address

126 EAST LINCOLN AVENUE P.O. BOX 2000

RAHWAY, NJ, 07065